title: [Parvovirus B19 infection after kidney transplantation].
abstract: Prevalence for human parvovirus B19 infection is estimated to be between 2% and 30% in renal transplant recipients. In post-transplant settings, parvovirus B19 infection may occur either as a primary infection or a reactivation. Parvovirus transmission most commonly occurs through respiratory tract but may also result from graft or blood packs contamination. Co-infections with HHV-6 and CMV viruses are frequent. The hallmark symptom is anemia, more rarely pancytopenia and hemophagocytic syndrome. In respect to renal involvement, parvovirus B19 infection has been associated with graft dysfunction in 10% of cases. Both thrombotic microangiopathies and collapsing glomerulopathies have been reported concomitantly with parvovirus B19 infection but the causal link remains unclear. Other complications are seldomly reported, including hepatitis, encephalitis, and myocarditis. Diagnosis is based on pre and post-transplant serological status. In addition, the management of parvovirus B19 infection in immunocompromised patients requires quantitative assessment of blood viral load by PCR. The treatment relies primarily on reduction of immunosuppression combined with intravenous immunoglobulin infusions. Relapses occur in 30% of cases.
authors.affiliation: Service de transplantation rénale adulte, université Paris-Descartes, hôpital Necker, 149-161, rue de Sèvres, 75015 Paris, France. albane.sartorius@nck.aphp.fr
authors.forename: Albane
authors.initials: A
authors.lastname: Brodin-Sartorius
authors.forename: Yahia
authors.initials: Y
authors.lastname: Mekki
authors.forename: Bénédicte
authors.initials: B
authors.lastname: Bloquel
authors.forename: Marion
authors.initials: M
authors.lastname: Rabant
authors.forename: Christophe
authors.initials: C
authors.lastname: Legendre
mesh_terms: D016731:Erythema Infectiosum / Q000150:complications / Q000175:diagnosis / Q000628:therapy / Q000821:virology; D006801:Humans; D016030:Kidney Transplantation; D016732:Parvovirus B19, Human; D011183:Postoperative Complications / Q000175:diagnosis / Q000628:therapy / Q000821:virology